Article summary
This week's edition of Life Sciences weekly highlights includes analysis of the EU Digital Services Act on IP rights and important news that the European Council approved amending the medical device regulations (the MDR and IVDR) extending the transition provisions and removing the ‘sell-off’ date for certain legacy devices with formal approval of the amending regulation set to occur next week, the DHSC is awarding £16m to developing nine AI technologies for the NHS while NICE approved eight digital therapies for depression and anxiety and the US FDA is seeking feedback on using AI for drug development, and the European pharmaceutical industry is advocating for a dynamic regulatory assessment (DRA) process to expedite the development of new treatments, among other stories.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial